“…While other deep learning methods require less preprocessing ( Bontempi et al, 2020 , Dolz et al, 2018 ), or produce tissue segmentations in less time than ours ( Guha Roy et al, 2019 , Bontempi et al, 2020 ), these methods ( Henschel et al, 2020 , Zhang et al, 2021 , Sendra-Balcells et al, 2020 , Tushar et al, 2019 ) were developed for and tested in healthy subjects or patients with diseases that do not present with focal brain lesions that alter signal and distort anatomy. More recently methods have been developed and tested in patients with a single pathology ( Mendrik et al, 2015 , Moeskops et al, 2016 , Luna and Park, 2018 , Chen et al, 2018 , de Boer et al, 2009 , Cai et al, 2020 , Valverde et al, 2017 , Liu et al, 2021 ). In contrast, our method was developed using a wide variety of gray and white matter pathologies.…”